Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
20%
Ph phase_1
2
13%
Ph not_applicable
6
40%
Ph phase_4
4
27%

Phase Distribution

2

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
2(13.3%)
Phase 3Large-scale testing
3(20.0%)
Phase 4Post-market surveillance
4(26.7%)
N/ANon-phased studies
6(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Active(1)
Completed(7)
Terminated(1)
Other(6)

Detailed Status

Completed7
unknown5
Suspended1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (13.3%)
Phase 33 (20.0%)
Phase 44 (26.7%)
N/A6 (40.0%)

Trials by Status

suspended17%
withdrawn17%
not_yet_recruiting17%
unknown533%
completed747%

Recent Activity

0 active trials
Showing 5 of 15
not_yet_recruitingphase_4

Dronedarone Rhythm Intervention for Early Atrial Fibrillation

NCT07270848
withdrawnnot_applicable

Beta-blocker vs. Ic Antiarrhythmic Drug for PVC

NCT03561935
unknownphase_4

Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.

NCT05720572
completednot_applicable

Propafenone in the Treatment of Atrial Fibrillation

NCT03674658
completedphase_1

Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

NCT03915340
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07270848Phase 4

Dronedarone Rhythm Intervention for Early Atrial Fibrillation

Not Yet Recruiting
NCT03561935Not Applicable

Beta-blocker vs. Ic Antiarrhythmic Drug for PVC

Withdrawn
NCT05720572Phase 4

Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.

Unknown
NCT03674658Not Applicable

Propafenone in the Treatment of Atrial Fibrillation

Completed
NCT03915340Phase 1

Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

Completed
NCT03895411Phase 4

Efficacy and Safety of Sotalol in Children With Arrhythmia

Unknown
NCT02633774Not Applicable

Comparison of Brain Perfusion in Rhythm Control and Rate Control of Persistent Atrial Fibrillation

Unknown
NCT01956487Phase 1

Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites

Completed
NCT02294955Not Applicable

Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)

Unknown
NCT00000556Phase 3

Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)

Completed
NCT02145546Phase 4

Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation

Unknown
NCT01991119Not Applicable

Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

Completed
NCT00000464Phase 3

Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)

Completed
NCT00933634Not Applicable

Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation

Completed
NCT00392106Phase 3

High Intensity Focused Ultrasound (HIFU) Ablation System Study

Suspended

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15